Neuronetics Inc (NASDAQ: STIM) kicked off on Tuesday, up 7.87% from the previous trading day, before settling in for the closing price of $1.27. Over the past 52 weeks, STIM has traded in a range of $0.92-$5.92.
A company in the Healthcare sector has jumped its sales by 2.71% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 56.57%. With a float of $41.82 million, this company’s outstanding shares have now reached $68.44 million.
Neuronetics Inc (STIM) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Neuronetics Inc is 38.94%, while institutional ownership is 31.14%. The most recent insider transaction that took place on Aug 08 ’25, was worth 13,020,000. In this transaction 10% Owner of this company sold 3,500,000 shares at a rate of $3.72, taking the stock ownership to the 1,142,351 shares. Before that another transaction happened on Aug 08 ’25, when Company’s 10% Owner proposed sale 2,925,554 for $3.72, making the entire transaction worth $10,883,061.
Neuronetics Inc (STIM) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.04 earnings per share (EPS), higher than consensus estimate (set at -0.24) by 0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 56.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.99% during the next five years compared to 2.71% growth over the previous five years of trading.
Neuronetics Inc (NASDAQ: STIM) Trading Performance Indicators
Take a look at Neuronetics Inc’s (STIM) current performance indicators. Last quarter, stock had a quick ratio of 2.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.72.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of Neuronetics Inc (STIM)
Let’s dig in a bit further. During the last 5-days, its volume was 1.94 million. That was better than the volume of 1.35 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 7.14%.
During the past 100 days, Neuronetics Inc’s (STIM) raw stochastic average was set at 3.33%, which indicates a significant decrease from 7.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2252 in the past 14 days, which was lower than the 0.2602 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.5457, while its 200-day Moving Average is $3.6238. However, in the short run, Neuronetics Inc’s stock first resistance to watch stands at $1.4167. Second resistance stands at $1.4633. The third major resistance level sits at $1.5417. If the price goes on to break the first support level at $1.2917, it is likely to go to the next support level at $1.2133. Assuming the price breaks the second support level, the third support level stands at $1.1667.
Neuronetics Inc (NASDAQ: STIM) Key Stats
The company with the Market Capitalisation of 93.83 million has total of 68,486K Shares Outstanding. Its annual sales at the moment are 74,890 K in contrast with the sum of -43,710 K annual income. Company’s last quarter sales were recorded 37,300 K and last quarter income was -9,050 K.
